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1. Introduction 
Immunoadjuvants hitherto known to induce 
delayed hypersensitivity and stimulate humoral anti- 
body production can be classified roughly into hydro- 
philic and hydrophobic substances. N-acetylmuramyl 
dipeptide [l-4] and arabinogalactan peptidoglycan 
of mycobacteria [5-71 are examples of hydrophilic 
adjuvants, while Wax D [8,9] , cord factor (trehalose 
dimycolate) of mycobacteria [lo] and lipopoly- 
saccharides of gram-negative bacteria [ 1 l] are hydro- 
phobic adjuvants. Dailey and Hunter [ 121 showed 
the increased hydrophobicity of hapten or protein 
can elicit delayed hypersensitivity. On the other hand, 
Allison and Gregoriades [ 131 reported negatively 
charged phospholipids can elevate humoral antibody 
level. These investigations predict that negatively 
charged phospholipids might elicit delayed hypersen- 
sitivity. Our examination of literature did not reveal 
such lines of experiments. One of the characteristics 
of membrane phospholipids in halophilic bacteria is a 
high content of negatively charged phospholipids 
[ 14-161 . 
This communication reports that negatively charged 
phospholipids of diacyl form from Pseudomonas halo- 
saccharolytica and animal tissues can elicit delayed 
hypersensitivity to protein antigen in guinea pigs, 
whereas phospholipids of the diphytanylether form 
from Halobacterium halobium are inactive. This was 
confirmed with synthetic phospholipids. 
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2. Materials and methods 
An extremely halophilic bacterium, Halobacterium 
halobium, was grown in medium containing 20% 
NaCl at 30°C for 72 h [ 171 and a moderately halo- 
philic bacterium, Pseudomonas halosaccharolytica 
ATCC 29423, was inoculated into a medium con- 
taining 10% NaCl at 30°C for 42 h in a reciprocal 
shaker [ 151 . The cells were harvested by centrifuga- 
tion, washed and kept in a frozen state. Lipids were 
extracted three times with chloroform-methanol 
(2 : 1, v/v) according to the method of Folch et al. 
[ 181 . Extractable lipids were separated on DEAE- 
cellulose column (acetate form) chromatography by 
the modification of Rauser et al. [ 191. Thus separated 
neutral and negatively charged phospholipid fractions 
were further separated into individual phospholipid 
by thin layer chromatography on Silica Gel (Merck) 
[ 161 . Quantitative estimation of each phospholipid 
was carried out by calorimetric determination of 
phosphorus. Fatty acids were analyzed by gas-liquid 
chromatography as methylesters as described pre- 
viously [ 161 . 
Diphosphatidylglycerol and phosphatidylserine 
from bovine brain, phosphatidylinositol from porcine 
liver, synthetic dioleoyl phosphatidylglycerol and 
dipalmitoyl phosphatidylcholine were purchased from 
Serdary Research Lab. (Canada). Fully saturated 
phospholipids were prepared by the direct hydro- 
genation of bovine brain diphosphatidylglycerol in the 
presence of platinum oxide. 
Crystalline ovalbumin (Grade V, Sigma) in saline 
was added to the dried phospholipids. After emulsi- 
fying with an equal volume of incomplete Freund’s 
237 
Volume 83, number 2 FEBS LETTERS November 1977 
adjuvant (IFA) (Difco) by sonicating for 5 min at room 
temperature, 0.2 ml of the water-in-oil emulsion was 
injected into a foot-pad of random-bred Hartley 
guinea pigs. Dose of antigen and phospholipids was 
1 mg and 0.1 mg/animal. Wax D ofMycobac&rium 
tuberculosis Aoyama B (gift of Dr A. Tanaka, Kyushu 
University, Japan) served as positive control, and 
IFA-antigen alone was used as negative control. Five 
animals weighing 3.50-400 g were used for each 
experiment. To test induction of delayed hypersensi- 
tivity to ovalbumin, 3 weeks after immunization, 
antigen solution (20 mg/ml saline) was injected into 
cornea of animals to make a transient disc of opacity 
of approx. 5 mm in a diameter (ca. 2 r_l1), and the 
resultant turbidity was evaluated 48 h later by the 
method of Kotani et al. [ 201 : 3, thickened and opaque 
cornea, pupil invisible; 2, diffusely turbid, pupil visible; 
1, locally turbid; 0, no visible difference from uninjected 
cornea. Skin test was performed intradermally with 
0.1 ml antigen solution (500 pg/ml saline) 3 weeks 
after immunization and the reaction was evaluated 
48 h later. Production of serum antibodies was deter- 
mined by a passive haemagglutination test 4 weeks later. 
3. Results and discussion 
Crude extractable lipids from P. halosaccharolytica 
induced a marked delayed hypersensitivity and elevated 
slightly antibody levels to ovalbumin in guinea pigs, 
whereas no elicitation of delayed hypersensitivity and 
no enhancement of antibody production were observed 
with the extractable lipids of H. halobium as shown 
in fig.1. The strong positive reaction in cornea 
continued from 24 h to 72 h and the skin test was also 
positive. Major components of extractable lipids in 
H. halobium are phosphatidylglycerophosphate 
[di-O-phytanyl-D~-glycerylphosphoryl-cY-glycerophos- 
phate] (diether form), phosphatidylglycerol [diO- 
phytanyl-Da-glycerylphosphoryl+glycerol] (diether 
form) and glycolipid sulfate [2,3-di-O-dihydrophytanyl- 
L-glycerol-l-0(glucosylmannosylgalactosyl) sulfate] 
[ 141. In contrast, major phospholipid components of 
P. halosaccharolytica are diacyl form phospholipids, 
phosphatidylglycerol, phosphatidylethanolamine, 
diphosphatidylglycerol and glucosylphosphatidyl- 
glycerol [ 151. This strongly suggests that negatively 
charged phospholipids in diacyl form are useful for 
the elicitation of delayed hypersensitivity, whereas 
diphytanylether form phospholipids are inactive. 
The negatively charged phospholipid fraction 
mainly composed of phosphatidylglycerol, diphos- 
phatidylglycerol and glucosylphosphatidylglycerol 
(roughly 1 : 2.5 : 1.4, w/w) in H. halosaccharolytica 
elicited delayed hypersensitivity and elevated slightly 
P halosacchalolytica H halobium 
< 
8 24 48 72 hrs 
Fig.1. Inducing ability of crude phospholipid fractions ofPseudomonas halosaccharolytica and Halobacterium halobium on 
delayed hypersensitivity in guinea pigs. Dose of crude phospholipid fractions used for the immunization was 0.2 mg/animal. 
Other immunological methods, see the text. Score of corneal reaction: crude phospholipids of P. halosaccharolytica (o), those of 
H. halobium (o), Wax D (A), negative control (0). Mean and range of antibody titer (X log 2) in cases of crude phospholipids of 
P. halosaccharolytica, those ofH. halobium, Wax D, and IFA alone were 14.3 (14-15), 11.6 (lo-14), 16.2 (14-19), and 13 
(lo-14), respectively. 
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Table 1 
Immunoadjuvant activities of phospholipids prepared from P. halosuccharolyticu and animal tissues, and 
of synthetic phospholipids 
Phospholipids Ratio Dose 
(mg) 
Cornea1 reaction 
Mean Range 
Skin reaction 
(mm) 
Mean t s.d. 
Antibody level 
(X log2) 
Mean Range 
Negatively charged 0.2 3.08 
phospholipid fraction 0.1 2.48 
of P. halosaccharolytica 0.05 2.38 
PGa/PGLa/CLa/PEa 1 : 1.4 : 2.5 : 3 0.4 2.3 
1 : 1.4 : 2.5 : 3 0.2 1.9 
PGa/PCLa/CLa 1 : 1.4 : 2.5 0.2 2.18 
PGa/PGLa 2:3 0.2 2sg 
PGa/CLa 2:s 0.2 2.5g 
CLa/PGLa 5:3 0.2 2.8g 
PGa/PEa 211 0.2 1.5 
PGa _ 0.2 O.Bh 
PGLa _ 0.2 0.2h 
CLa _ 0.2 1.4 
PEa _ 0.2 1 .oh 
CLb/PGc 1 : 1 0.2 1.9g 
CLblPSb 1 : 1 0.2 2.2 
CLb/PId 1:1 0.2 2.1 
CLe/PGc 1:1 0.2 1.5 
CLelPCf 1 : 1 0.2 1.2 
CLb _ 1.0 1.3 
CLb _ 0.2 0.9 
Wax D _ 0.2 2.6 
_ _ _ 0.5 
(3.0-3.0) 
(1.0-3.0) 
(1.5-3.0) 
(1.0-3.0) 
(1.5-2.5) 
(1.5-3.0) 
(2.0-3.0) 
(2.0-3.0) 
(2.5-3.0) 
(0.5 -2.0) 
(O-2.0) 
(O-1.0) 
(0.5 -3.0) 
(O-2.0) 
(0.5-3.0) 
(2.0-3.0) 
(1.0-3.0) 
(O-2.5) 
(O-2.0) 
(O-2.0) 
(1.0-2.0) 
(2.5-3.0) 
(O-2.0) 
10.0 f 2.8 
13.0 f 2.98 
12.0* 5.08 
10.5 + 1.9 
8.3 + 3.0 
6.3 + 3.8 
15.0 * 10.6 
11.0 * 11.4 
15.8 * 9.8 
7.2 + 3.1 
2.0 + 1.5h 
0 f 0.4h 
14.0 * 4.5 
3.0 f 2.0h 
9.8 ?: 6.9 
9.9 +_ 3.0 
9.0 f 3.6 
7.4 i 4.3 
6.8 * 4.1 
8.4 * 1.6 
5.5 * 4.4 
15.1 * 7.7 
4.1 * 3.8 
14.6 (13-16) 
15.8 (14-17) 
14.8 (13-17) 
16.38 (15.-17) 
15.8 (13-17) 
16.08 (15-17) 
14.2 (12-17) 
13.8 (13-14) 
14.4 (12-17) 
13.8 (12-17) 
12.Bh (12-15) 
12.6h (11-15) 
14.3 (12-16) 
13.4h (11-16) 
15.48 (14-18) 
16.1 (14-20) 
17.2 (16-20) 
16.2 (14-18) 
14.5 (12-17) 
13.5h (13-15) 
16.2 (14-19) 
13.0 (10-14) 
aFrom P. halosaccharolytica 
bFrom bovine brain 
‘Dioleoyl PG 
dFrom porcine liver 
eHydrogenated C 1 from bovine brain 
f Dipalmitoyl PC 
gsignificant difference between the value and that of a negative control (P < 0.05) 
hNo significant difference between the value and that of a negative control (P < 0.05) 
.Abbreviations: PG, phosphatidylglycerol; PGL, glucosylphosphatidylglycerol; CL, diphosphatidylglycerol; PE, phosphatidyl- 
ethanolamine; PS, phosphatidylserine; PI, phosphatidylinositol; PC, phosphatidylcholine 
antibody level (table l), even when smaller amounts 
of phospholipid (50 pg) were used. Mixtures of two 
or more kinds of negatively charged phospholipids 
were active, while the single species of phospholipids 
or the mixture of a negatively charged phospholipid 
(phosphatidylglycerol) and a neutral phospholipid 
(phosphatidylethanolamine) were without effect. 
Major fatty acids of phospholipids from P. halo- 
saccharolytica are C16:e (42.8%), C17 (6.5%) and Cr9 
(39.2%) cyclopropanoic acid [ 151, while those of 
diphosphatidylglycerol, and phosphatidylserine from 
bovine brain, and phosphatidylinositol from porcine 
liver were C1e:O (8.6%),Crs:r (11.9%)andCrs:2 
(61%); Crs:a (53.3%) and Crs:r (40.6%); Crs:o (48.3%) 
C ra:r (13.1%), C1sz2 (6.5%) and CZO:~ (26.5%) 
respectively. Mixtures of two kinds of the animal 
phospholipids were also an active adjuvant, while the 
diphosphatidylglycerol alone was less active as in the 
case of bacterial phospholipids. Hydrogenated diphos- 
phatidylglycerol [major fatty acids, C 16: 0 (12.6%) 
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and Crs:u (71%)] was less active in the induction of 
delayed hypersensitivity, whereas it still enhanced 
antibody production slightly. A mixture of synthetic 
dipalmitoyl phosphatidylcholine and the hydrogenated 
diphosphatidylglycerol reduced adjuvant activity for 
delayed hypersensitivity. 
To elicit delayed hypersensitivity in random-bred 
Hartley guinea pigs, co-existence of at least two kinds 
of negatively charged phospholipids (diacyl form) was 
necessary. It was also indicated that the number of 
carbon atoms, the degree of unsaturation, branching 
and cyclopropane rings in the acyl moiety of nega- 
tively charged phospholipids may affect the adjuvant 
activity, in relation to the rigidity of lipid vesicles. 
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